BMI1 and cancer: In addition, PTC-209 exhibited an irreversible decrease in the sphere formation ability of primary colorectal tumors in vitro and tumor formation in vivo following a limited dilution assay, suggesting that inhibition of BMI1 has the potential to target chemo-resistant cancer-initiating cells.